The scientific and clinical basis for the treatment of Parkinson disease (2009)
Olanow et al.
Neurology 2009;72:S1-S136.
ABSTRACT
| FULL TEXT
Levodopa and the Progression of Parkinson's Disease
The Parkinson Study Group
NEJM 2004;351:2498-2508.
ABSTRACT
| FULL TEXT
Case study: cerebrovascular parkinsonism with levodopa addiction
Lily and Al-Din
J. Neurol. Neurosurg. Psychiatry 2004;75:1365-1366.
FULL TEXT
Paroxysmal Autonomic Instability With Dystonia After Brain Injury
Blackman et al.
Arch Neurol 2004;61:321-328.
ABSTRACT
| FULL TEXT
Subthalamic DBS replaces levodopa in Parkinson's disease: Two-year follow-up
Vingerhoets et al.
Neurology 2002;58:396-401.
ABSTRACT
| FULL TEXT
An algorithm (decision tree) for the management of Parkinson's disease (2001):: Treatment
Olanow et al.
Neurology 2001;56:S1-S88.
FULL TEXT
Susceptibility to neuroleptic malignant syndrome in Parkinson's disease
Ueda et al.
Neurology 1999;52:777-777.
ABSTRACT
| FULL TEXT
Neuroleptic Malignant Syndrome: A Review
Pelonero et al.
Psychiatr. Serv. 1998;49:1163-1172.
ABSTRACT
| FULL TEXT
Neuroleptic Malignant Syndrome in Parkinson's Disease After Withdrawal or Alteration of Dopaminergic Therapy
Keyser and Rodnitzky
Arch Intern Med 1991;151:794-796.
ABSTRACT
Risk Factors for Neuroleptic Malignant Syndrome: A Case-Control Study
Keck et al.
Arch Gen Psychiatry 1989;46:914-918.
ABSTRACT
Neuroleptic Malignant Syndrome
Sandyk and Iacono
JAMA 1986;255:2291-2291.
ABSTRACT